NCT02678338 CAMELLIA: Anti-CD47 Antibody Therapy in Haematological Malignancies Status COMPLETED Phase PHASE1
NCT02676323 Panobinostat With Fludarabine and Cytarabine for Treatment of Children With Acute Myeloid Leukemia or Myelodysplastic Syndrome Status TERMINATED Phase PHASE1
NCT02674763 Open-label Study of IMGN779 in Adult Patients With Relapsed/Refractory CD33-positive Acute Myeloid Leukemia Status COMPLETED Phase PHASE1
NCT02671708 IDA+BUCY vs BUCY Conditioning Regimen for Intermediate-risk AML Undergoing Auto-HSCT Status COMPLETED Phase PHASE2/PHASE3
NCT02668653 Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML) Status COMPLETED Phase PHASE3
NCT02667093 Samples From Leukemia Patients and Their Donors to Identify Specific Antigens Status UNKNOWN Phase N/A
NCT02665065 Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02646839 KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children Status ENROLLING_BY_INVITATION Phase PHASE2
NCT02614560 A Study of Vadastuximab Talirine Given Prior to or After Allogeneic Hematopoietic Stem Cell Transplant in AML Patients Status TERMINATED Phase PHASE1/PHASE2
NCT02610062 A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Doses of AGS67E Given as Monotherapy in Subjects With Acute Myeloid Leukemia (AML) Status TERMINATED Phase PHASE1
NCT02605460 Chemo Sensitization Before Hematopoietic Stem Cell Transplantation in Patients With Acute Leukemia in Complete Remission Status UNKNOWN Phase PHASE2
NCT02602587 Study of Dendrogenin A / Oxysterols Balance Between Healthy Volunteers and Acute Myeloid Leukemia Patients Status COMPLETED Phase NA
NCT02598752 Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation Status COMPLETED Phase N/A
NCT02588092 Study of ADCT-301 in Patients With Relapsed/Refractory CD25-positive Acute Myeloid Leukemia (AML) or CD25-positive Acute Lymphoblastic Leukemia (ALL) Status TERMINATED Phase PHASE1
NCT02582359 MLN 9708 in Induction and Consolidation for Adults With AML >= 60 Years of Age Status COMPLETED Phase PHASE1
NCT02573363 Selinexor With Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia Status COMPLETED Phase PHASE1
NCT02566304 Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies Status COMPLETED Phase PHASE2
NCT02561455 Rollover Study for Subjects Who Have Participated in an Astellas Sponsored ASP2215 Trial Status COMPLETED Phase PHASE1/PHASE2
NCT02560025 Phase II Trial of Alisertib With Induction Chemotherapy in High-risk AML Status COMPLETED Phase PHASE2